Plain Language Summaries is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • How to
  • FAQs
  • Publications
  • Advisory Panel
    • Plain Language Advisors
    • Scientific Content Advisors
  • Supporters
  • Blog
  • About us
  • Contact Us

Migraine

18th Jul 2025

Plain language summary: research findings on eptinezumab for migraine prevention in patients who didn’t respond to previous treatments

17th Jul 2025

Plain language summary: research on taking rimegepant by mouth to reduce migraine frequency

27th May 2025

Plain language summary: clinical study findings on rimegepant melt-in-mouth tablets for treating migraine attacks

24th Sep 2024

A plain language summary of a population-based survey on Americans with frequent migraines and their use of acute medications

This is a summary of three articles describing preventive treatment of migraine in participants with a diagnosis of both chronic migraine and medication-overuse headache in a study called PROMISE-2 (PRevention Of Migraine via Intravenous ALD403 Safety and Efficacy–2). People living with chronic migraine and medication-overuse headache have one of the most disabling, costly, and difficult-to-treat headache disorders
28th Jun 2023

Plain Language Summary: treatment with eptinezumab for migraine prevention in people with chronic migraine and medication-overuse headache

Copyright © 2026 · Plain Language Summaries · Terms and conditions · Privacy policy · Cookie policy